CNN: One of the leading coronavirus vaccine trials is currently paused. Prominent vaccine researchers say that's unusual
UC expert says phase III trials typically don't pause
Recently, one of the major trials being conducted for a COVID-19 vaccine was paused because a study volunteer had what's known as an "adverse event." Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by CNN for a story on the pause in the AstraZeneca COVID-19 vaccine trial.
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases. Photo/Joseph Fuqua III/UC Creative + Brand
Fichtenbaum said it was uncommon for a pause to happen in a phase III trial.
According to Fichtenbaum, "Phase 3 trials don't typically pause. I've only seen it handful of times in my experience."
Read the entire story here.
Fichtenbaum was also featured in a story on vaccine trial volunteers aired by several Hearst television stations, including WCVB in Boston.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Ohio ranked No. 1 for business by CNBC
July 10, 2026
Ohio is CNBC’s No. 1 Top State for Business in 2026. The University of Cincinnati helps fuel that success through co-op, innovation, talent development and close collaboration with the state.
UC students organize free health clinic happening July 11-12
July 10, 2026
The University of Cincinnati student chapter of Remote Area Medical is holding its annual free health clinic July 11-12. The clinic is open to adults and children, with no income requirements. Anyone in the area who needs medical, dental or vision care will have a chance to get it for free, with no insurance required.
Hoxworth Blood Center CEO advocates on Capitol Hill during National Blood Advocacy Week
July 9, 2026
Hoxworth Blood Center, University of Cincinnati, has announced that David Oh, MD, director and chief executive officer, joined blood center leaders, patient advocates and partner organizations in Washington, D.C., in June as part of Blood Advocacy Week, a national initiative led by America’s Blood Centers to strengthen the nation’s blood supply.